DUSP3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.598000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.582200E-01
Normal-vs-Stage2
8.069000E-01
Normal-vs-Stage3
6.691400E-01
Normal-vs-Stage4
3.958000E-01
Stage1-vs-Stage2
8.033800E-01
Stage1-vs-Stage3
7.710400E-01
Stage1-vs-Stage4
7.477800E-01
Stage2-vs-Stage3
6.991000E-01
Stage2-vs-Stage4
1.949780E-01
Stage3-vs-Stage4
8.489800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.720400E-01
Normal-vs-AfricanAmerican
5.718400E-01
Normal-vs-Asian
7.755600E-01
Caucasian-vs-AfricanAmerican
8.993600E-01
Caucasian-vs-Asian
9.175800E-01
AfricanAmerican-vs-Asian
9.594000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.203400E-01
Normal-vs-Female
6.881000E-01
Male-vs-Female
4.750600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.032600E-01
Normal-vs-Age(41-60Yrs)
4.326600E-01
Normal-vs-Age(61-80Yrs)
9.570200E-01
Normal-vs-Age(81-100Yrs)
7.063600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.488400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.859400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.633000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.202490E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.455800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.451600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.520200E-01
Normal-vs-Daily Drinker
8.198600E-01
Normal-vs-Weekly Drinker
6.136200E-01
Normal-vs-Occasional Drinker
8.523600E-01
Normal-vs-Social Drinker
5.023200E-01
Non Drinker-vs-Daily Drinker
9.899600E-01
Non Drinker-vs-Weekly Drinker
1.806640E-01
Non Drinker-vs-Occasional Drinker
4.628200E-01
Non Drinker-vs-Social Drinker
1.055990E-01
Daily Drinker-vs-Weekly Drinker
1.578820E-01
Daily Drinker-vs-Occasional Drinker
4.209800E-01
Daily Drinker-vs-Social Drinker
1.030640E-01
Weekly Drinker-vs-Occasional Drinker
4.604800E-01
Weekly Drinker-vs-Social Drinker
4.624200E-01
Occasional Drinker-vs-Social Drinker
2.095600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.262200E-01
Normal-vs-Grade 2
1.802790E-01
Normal-vs-Grade 3
8.567700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.545200E-01
Grade 1-vs-Grade 3
5.072800E-01
Grade 1-vs-Grade 4
3.262200E-01
Grade 2-vs-Grade 3
2.470000E-01
Grade 2-vs-Grade 4
1.802790E-01
Grade 3-vs-Grade 4
8.567700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.311600E-01
Normal-vs-NonDiabetic
6.627400E-01
Diabetic-vs-NonDiabetic
1.651400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.335600E-01
Normal-vs-NoPancreatitis
8.398800E-01
Pancreatitis-vs-NoPancreatitis
4.427400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.874600E-01
Normal-vs-N1
7.717600E-01
N0-vs-N1
9.848600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.535600E-01
Normal-vs-TP53-NonMutant
9.322000E-01
TP53-Mutant-vs-TP53-NonMutant
7.478600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
